# NLR and PLR Levels Following IPACK Block in Knee Arthroplasty

> **NCT06304298** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Knee Arthropathy
- Knee Osteoarthritis
- Knee Pain Chronic

## Interventions

- **DRUG:** 0.9% Sodium Chloride Injection
- **DRUG:** Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT06304298
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-30
- **Primary completion:** 2025-01-16
- **Final completion:** 2025-02-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304298, "NLR and PLR Levels Following IPACK Block in Knee Arthroplasty". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06304298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*